EU approves AbbVie's Rinvoq for severe alopecia areata

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. NVDA
2. ORCL
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to EU approves AbbVie's Rinvoq for severe alopecia areata
AbbVie (NYSE: ABBV) Delayed: 261.51 +4.39 (1.71%)
Previous Close $257.12    52 Week High $68.12 
Open $261.67    52 Week Low $50.71 
Day High $264.65    P/E 56.73 
Day Low $260.10    EPS $4.61 
Volume 1,958,944